Недавно објављени чланци

Karkouti K, Callum JL, Bartoszko J, Tanaka KA, Knaub S, Brar S, Ghadimi K, Rochon A, Mullane D, Couture EJ, Lin Y, Harle C, Zeller M, Tran DTT, Solomon C, Rao V, Law M, Butt AL, Chen EP, Martins MR, Saha T, Shih AW, Vézina MC, Moussa F, Pereira Cezar Zamper R, Syed S, Buyukdere H, Werner S, Grewal D, Wong D, Vandyck KB, Tanzola R, Hughes B, Royer O, Wong S, Levy JH; FARES-II Study Group

Извор‎: JAMA 2025;333(20):1781-92.

Индекс‎: PubMed 40156829

DOI‎: 10.1001/jama.2025.3501

https://pubmed.ncbi.nlm.nih.gov/40156829/ (отвара нови прозор)

Efficacy and utility of antifibrinolytics in pediatric spine surgery: a systematic review and network meta-analysis. (отвара нови прозор)

Aghajanian S, Mohammadifard F, Kohandel Gargari O, Naeimi A, Bahadorimonfared A, Elsamadicy AA

Извор‎: Neurosurg Rev 2024;47(1):177.

Индекс‎: PubMed 38644447

DOI‎: 10.1007/s10143-024-02424-x

https://pubmed.ncbi.nlm.nih.gov/38644447/ (отвара нови прозор)

Successful treatment of AML using non-intensive chemotherapy in Jehovah's Witness patients. (отвара нови прозор)

Page D, Sawler D, Brandwein J

Извор‎: Leuk Res Rep 2024;22:100477.

Индекс‎: PubMed 39238534

DOI‎: 10.1016/j.lrr.2024.100477

https://pubmed.ncbi.nlm.nih.gov/39238534/ (отвара нови прозор)

Safety and efficacy of tranexamic acid in general surgery. (отвара нови прозор)

Park LJ, Marcucci M, Ofori SN, Borges FK, Nenshi R, Kanstrup CTB, Rosen M, Landoni G, Lomivorotov V, Painter TW, Xavier D, Martinez-Zapata MJ, Szczeklik W, Meyhoff CS, Chan MTV, Simunovic M, Bogach J, Serrano PE, Balasubramanian K, Cadeddu M, Yang I, Kim WH, Devereaux PJ

Извор‎: JAMA Surg 2025;160(3):267-74.

Индекс‎: PubMed 39813061

DOI‎: 10.1001/jamasurg.2024.6048

https://pubmed.ncbi.nlm.nih.gov/39813061/ (отвара нови прозор)

Total hip arthroplasty was found to be safe in Jehovah's Witness patients: a multi-centered matched study. (отвара нови прозор)

Leal J, Kugelman DN, Ward SA, Wixted CM, Lajam CM, Schwarzkopf R, Seyler TM

Извор‎: Arch Orthop Trauma Surg 2025;145(1):103.

Индекс‎: PubMed 39738842

DOI‎: 10.1007/s00402-024-05740-5

https://pubmed.ncbi.nlm.nih.gov/39738842/ (отвара нови прозор)

Impact of perioperative blood transfusion on postoperative outcomes in neonates. (отвара нови прозор)

Fazzone B, Kashif R, Neal D, Raymond R, Berg MT, Savani RC, Do AR, Taylor JA, Larson SD, Raymond SL

Извор‎: J Pediatr Surg 2025;60(3):162129.

Индекс‎: PubMed 39793532

DOI‎: 10.1016/j.jpedsurg.2024.162129

https://pubmed.ncbi.nlm.nih.gov/39793532/ (отвара нови прозор)

Effects of intravenous tranexamic acid on bleeding during burn surgery: a double-blinded randomized clinical trial. (отвара нови прозор)

Naderi MA, Moghadam AD, Mobayen M, Rimaz S, Haghani-Dogahe Z, Roudsarabi S, Tolouei M, Zarei R

Извор‎: Burns 2025;51(1):107270.

Индекс‎: PubMed 39522372

DOI‎: 10.1016/j.burns.2024.09.009

https://pubmed.ncbi.nlm.nih.gov/39522372/ (отвара нови прозор)

Recombinant erythropoietin for the treatment of iron deficiency anemia in pregnancy: a systematic review. (отвара нови прозор)

Levy AT, Weingarten SJ, Robinson K, Suner T, McLaren RA Jr, Saad A, Al-Kouatly HB

Извор‎: Int J Gynaecol Obstet 2025;168(1):35-42.

Индекс‎: PubMed 39087437

DOI‎: 10.1002/ijgo.15811

https://pubmed.ncbi.nlm.nih.gov/39087437/ (отвара нови прозор)

Practice advisory on the implementation of preoperative anemia management: the Society of Cardiovascular Anesthesiologists and the Society for the Advancement of Patient Blood Management. (отвара нови прозор)

Klompas AM, Hensley NB, Burt JM, Grant MC, Guinn NR, Patel PA, Popescu WM, Raphael J, Salenger R, Shore-Lesserson L, Warner MA

Извор‎: Anesth Analg 2024.

Индекс‎: PubMed 39671507

DOI‎: 10.1213/ANE.0000000000007321

https://pubmed.ncbi.nlm.nih.gov/39671507/ (отвара нови прозор)

A practical guide to reducing/eliminating red blood cell transfusions in the neonatal intensive care unit. (отвара нови прозор)

Ohls RK, Bahr TM, Peterson TG, Christensen RD

Извор‎: Semin Fetal Neonatal Med 2024:101545.

Индекс‎: PubMed 39477716

DOI‎: 10.1016/j.siny.2024.101545

https://pubmed.ncbi.nlm.nih.gov/39477716/ (отвара нови прозор)

Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial. (отвара нови прозор)

Della Porta MG, Garcia-Manero G, Santini V, Zeidan AM, Komrokji RS, Shortt J, Valcárcel D, Jonasova A, Dimicoli-Salazar S, Tiong IS, Lin CC, Li J, Zhang J, Pilot R, Kreitz S, Pozharskaya V, Keeperman KL, Rose S, Prebet T, Lai Y, Degulys A, Paolini S, Cluzeau T, Fenaux P, Platzbecker U

Извор‎: Lancet Haematol 2024;11(9):e646-58.

Индекс‎: PubMed 39038479

DOI‎: 10.1016/S2352-3026(24)00203-5

https://pubmed.ncbi.nlm.nih.gov/39038479/ (отвара нови прозор)

Изабери језик